FIELD: medicine.
SUBSTANCE: invention refers to genetic engineering and can be used for methane-producing cell permeability control. What is prepared is a polypeptide able to permeate into a methane-producing cell and to increase its permeability, characterised by an amino acid sequence SEQ ID NO:117, 118 or 119 or being at least 90% identical to the above sequence, or at least 15 sequential amino acids of the above sequence. What is also prepared is a polynucleotide coding the above polypeptide cloning and expressing vectors used for producing host cells producing the polypeptide or used for the vector replication. The polypeptide can contain a fluorescent tag on an N-terminal amino acid residue.
EFFECT: invention enables providing higher methane-producing cell permeability.
18 cl, 35 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
VACCINES AND VACCINE INGREDIENTS FOR MICROBIAL CELL INHIBITION | 2008 |
|
RU2528854C2 |
PHAGE φ-mru POLYNUCLEOTIDES AND POLYPEPTIDES AND THEIR APPLICATION | 2008 |
|
RU2520738C2 |
EXPRESSION OF NEW CELL MARKS | 2018 |
|
RU2796334C2 |
SIGNAL PEPTIDES TAT FOR PRODUCTION OF PROTEINS IN PROCARYOTES | 2008 |
|
RU2487937C2 |
NEW GENES CODING NEW PROTEOLYTIC ENZYMES | 2002 |
|
RU2423525C2 |
MULTI-CHAIN CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF | 2013 |
|
RU2663725C2 |
IMMUNOGENS FOR VACCINATION AGAINST HIV | 2013 |
|
RU2648791C2 |
POLYNUCLEOTIDE MODULATING CANCER CELL PROLIFERATION (VARIANTS), POLYPEPTIDE, MONOCLONAL ANTIBODY, EXPRESSION VECTOR, HOST CELL, PHARMACEUTICAL AGENT FOR TREATMENT OF PROLIFERATIVE DISEASE, PHARMACEUTICAL COMPOSITION, POLYPEPTIDE USES IN PHARMACEUTICAL AGENT PRODUCTION | 2002 |
|
RU2307666C2 |
NEW GENES ENCODING NEW PROTEOLYTIC ENZYMES | 2002 |
|
RU2296160C2 |
SILK PROTEINS | 2006 |
|
RU2467015C2 |
Authors
Dates
2014-08-20—Published
2008-09-25—Filed